This grant is designed to help reduce illness and death caused by Hereditary Hemorrhagic Telangiectasia (HHT), a rare disease. The program aims to work with clinical centers to improve access to care, help doctors diagnose HHT, and create a patient data registry to understand the disease better.
Who it's for: This grant is for state governments and potentially other unspecified entities that can partner with clinical centers to improve care for HHT patients.
More details
Likely Disqualifiers
- Not being a state government or an eligible 'other' entity
- Inability to partner with a clinical center
- Failure to propose innovative strategies for HHT diagnosis
- Lack of capacity to develop a patient data registry
- Missing the application deadline
What You May Need
- Proof of eligibility as a state government or other qualifying entity
- Partnership agreements with clinical centers
- A detailed plan for innovative HHT diagnosis strategies
- Proposal for developing a patient data registry
- Financial statements or budget plans
- Organizational capacity documentation
- Completed application forms
- Letters of support or commitment
- Project timeline and milestones
Cautions
- Ensure eligibility as either a state government or an 'other' entity
- Strict deadline for application submission
- Requirement to partner with clinical centers
- Need for innovative approaches to diagnosis
- Development of a patient data registry is essential
Generated from official source details for readability
Eligibility
Eligible Applicant Types
Additional Criteria
Eligible applicants include state governments and potentially other entities that can partner with clinical centers to improve care for HHT patients. The specific nature of 'other' eligible entities is not detailed, so it is important to consult the official grant documentation or contact the grant administrator for clarification.
Overview
This grant is for state governments and potentially other unspecified entities that can partner with clinical centers to improve care for HHT patients.
Likely Disqualifiers
- Not being a state government or an eligible 'other' entity
- Inability to partner with a clinical center
- Failure to propose innovative strategies for HHT diagnosis
- Lack of capacity to develop a patient data registry
- Missing the application deadline
Use of Funds
The funds can be used to partner with clinical centers, create strategies for better diagnosis of HHT, and develop a patient data registry to improve understanding and treatment of the disease.
Total Program Funding
$2,900,000
Expected Awards
1
Cost Sharing
Not Required
Important Dates
- Posted
- Jun 8, 2026
- Deadline
- Jul 10, 2026(27 days)
- Archive Date
- Aug 30, 2026
Application Checklist
- Verify eligibility as a state government or other qualifying entity
- Establish partnerships with clinical centers
- Draft a plan for innovative HHT diagnosis strategies
- Outline a proposal for a patient data registry
- Prepare financial and organizational documents
- Complete all required application forms
- Gather letters of support or commitment
- Create a project timeline with milestones
- Submit application by the deadline